These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary. Leonhardt K; Einenkel J; Sohr S; Engeland K; Horn LC Int J Gynecol Pathol; 2011 Sep; 30(5):417-24. PubMed ID: 21804388 [TBL] [Abstract][Full Text] [Related]
9. Mixed endometrial carcinomas with a "low-grade serous"-like component: a clinicopathologic, immunohistochemical, and molecular genetic study. Espinosa I; D'Angelo E; Corominas M; Gonzalez A; Prat J Hum Pathol; 2018 Jan; 71():65-73. PubMed ID: 29079180 [TBL] [Abstract][Full Text] [Related]
10. Endometrial intraepithelial carcinoma with associated peritoneal carcinomatosis. Soslow RA; Pirog E; Isacson C Am J Surg Pathol; 2000 May; 24(5):726-32. PubMed ID: 10800992 [TBL] [Abstract][Full Text] [Related]
11. Serous endometrial intraepithelial carcinoma (SEIC): Current clinical practice in The Netherlands. Slaager C; Hofhuis W; Hoogduin K; Ewing-Graham P; van Beekhuizen H Eur J Obstet Gynecol Reprod Biol; 2021 Oct; 265():25-29. PubMed ID: 34416579 [TBL] [Abstract][Full Text] [Related]
12. [Serous genital carcinoma: molecular pathogenesis and the role of tubal fimbria]. Lax S Pathologe; 2009 Dec; 30 Suppl 2():210-6. PubMed ID: 19859709 [TBL] [Abstract][Full Text] [Related]
13. Wilms tumor gene immunoreactivity in primary serous carcinomas of the fallopian tube, ovary, endometrium, and peritoneum. Hashi A; Yuminamochi T; Murata S; Iwamoto H; Honda T; Hoshi K Int J Gynecol Pathol; 2003 Oct; 22(4):374-7. PubMed ID: 14501819 [TBL] [Abstract][Full Text] [Related]
14. Evidence for a latent precursor (p53 signature) that may precede serous endometrial intraepithelial carcinoma. Jarboe EA; Pizer ES; Miron A; Monte N; Mutter GL; Crum CP Mod Pathol; 2009 Mar; 22(3):345-50. PubMed ID: 19151662 [TBL] [Abstract][Full Text] [Related]
15. Concurrent endometrial intraepithelial carcinoma (EIC) and serous ovarian cancer: can EIC be seen as the precursor lesion? Roelofsen T; van Kempen LC; van der Laak JA; van Ham MA; Bulten J; Massuger LF Int J Gynecol Cancer; 2012 Mar; 22(3):457-64. PubMed ID: 22249577 [TBL] [Abstract][Full Text] [Related]
16. TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesions. Kuhn E; Kurman RJ; Vang R; Sehdev AS; Han G; Soslow R; Wang TL; Shih IeM J Pathol; 2012 Feb; 226(3):421-6. PubMed ID: 21990067 [TBL] [Abstract][Full Text] [Related]
17. Primary sources of pelvic serous cancer in patients with endometrial intraepithelial carcinoma. Jia L; Yuan Z; Wang Y; Cragun JM; Kong B; Zheng W Mod Pathol; 2015 Jan; 28(1):118-27. PubMed ID: 24925054 [TBL] [Abstract][Full Text] [Related]
18. Papillary serous carcinoma of the peritoneum coexisting with or after endometrial carcinoma. Altaras MM; Bernheim J; Zehavi T; Drucker L; Uziel O; Fishman A Gynecol Oncol; 2002 Feb; 84(2):245-51. PubMed ID: 11812082 [TBL] [Abstract][Full Text] [Related]
19. Differential expression of WT-1 in serous carcinomas in the peritoneum with or without associated serous carcinoma in endometrial polyps. Euscher ED; Malpica A; Deavers MT; Silva EG Am J Surg Pathol; 2005 Aug; 29(8):1074-8. PubMed ID: 16006803 [TBL] [Abstract][Full Text] [Related]
20. Endometrial glandular dysplasia with frequent p53 gene mutation: a genetic evidence supporting its precancer nature for endometrial serous carcinoma. Jia L; Liu Y; Yi X; Miron A; Crum CP; Kong B; Zheng W Clin Cancer Res; 2008 Apr; 14(8):2263-9. PubMed ID: 18369088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]